Marco, C.; Simó, M.; Alemany, M.; Casasnovas, C.; DomÃnguez, R.; Vilariño, N.; Calvo, M.; MartÃn-Liberal, J.; Brenes, J.; Sabater-Riera, J.;
et al. Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series. J. Clin. Med. 2023, 12, 130.
https://doi.org/10.3390/jcm12010130
AMA Style
Marco C, Simó M, Alemany M, Casasnovas C, DomÃnguez R, Vilariño N, Calvo M, MartÃn-Liberal J, Brenes J, Sabater-Riera J,
et al. Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series. Journal of Clinical Medicine. 2023; 12(1):130.
https://doi.org/10.3390/jcm12010130
Chicago/Turabian Style
Marco, Carla, Marta Simó, Montse Alemany, Carlos Casasnovas, Raúl DomÃnguez, Noelia Vilariño, Mariona Calvo, Juan MartÃn-Liberal, Jesús Brenes, Joan Sabater-Riera,
and et al. 2023. "Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series" Journal of Clinical Medicine 12, no. 1: 130.
https://doi.org/10.3390/jcm12010130
APA Style
Marco, C., Simó, M., Alemany, M., Casasnovas, C., DomÃnguez, R., Vilariño, N., Calvo, M., MartÃn-Liberal, J., Brenes, J., Sabater-Riera, J., Bruna, J., & Velasco, R.
(2023). Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series. Journal of Clinical Medicine, 12(1), 130.
https://doi.org/10.3390/jcm12010130
